E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/22/2021 in the Prospect News Emerging Markets Daily.

New Issue: Huaxin Pharmaceutical sells $146 million 5% notes due 2024

By Taylor Fox

New York, Feb. 22 – Huaxin Pharmaceutical (Hong Kong) Co. Ltd. sold $146 million of 5% guaranteed notes due 2024, according to a company announcement.

The bonds are guaranteed by Taizhou Huaxin Pharmaceutical Investment Co. Ltd.

China Industrial Securities International is the joint bookrunner and joint lead manager while China Minsheng Banking Corp., Ltd., Hong Kong Branch; Industrial Bank Co., Ltd. Hong Kong Branch; Fosun Hani and Guoyuan Capital are joint global coordinators, joint bookrunners and joint lead managers.

Bank of Nanjing Co., Ltd.; Industrial Bank Co., Ltd. Taizhou Branch and China Minsheng Banking Corp., Ltd., Taizhou Branch are the PRC coordinators.

The bonds are expected to be listed on the Stock Exchange of Hong Kong Ltd. on Tuesday.

The drug wholesale and distribution company is based in Taizhou, China.

Issuer:Huaxin Pharmaceutical (Hong Kong) Co. Ltd.
Guarantor:Taizhou Huaxin Pharmaceutical Investment Co. Ltd.
Amount:$146 million
Description:Guaranteed notes
Maturity:2024
Bookrunners:China Industrial Securities International, China Minsheng Banking Corp., Ltd., Hong Kong Branch; Industrial Bank Co., Ltd. Hong Kong Branch; Fosun Hani and Guoyuan Capital
Coupon:5%
Announcement date:Feb. 22
Listing date:Feb. 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.